FEMINONE

Pre-Launch

ethinyl estradiol

NDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
20

Mechanism of Action

ovulation.

Indications (1)

Clinical Trials (5)

NCT07446400Phase 1Not Yet Recruiting

A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

Started Mar 2026
48 enrolled
Healthy Volunteers
NCT07272889Phase 1Not Yet Recruiting

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

Started Dec 2025
NCT07013643Phase 1Recruiting

A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

Started Jun 2025
75 enrolled
Healthy Participants
NCT06657105Phase 1Completed

A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

Started Nov 2024
22 enrolled
Healthy Participants
NCT06380205Phase 1Completed

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

Started May 2024
24 enrolled
Healthy Participants